Booz Allen Hamilton to Acquire Peraton Labs

Ticker: BAH · Form: 8-K · Filed: Aug 13, 2024 · CIK: 1443646

Sentiment: neutral

Topics: acquisition, R&D, AI, cybersecurity

Related Tickers: BAH, PRN

TL;DR

BAH buying Peraton Labs to boost AI/cyber R&D, closing Q3 FY25.

AI Summary

Booz Allen Hamilton Holding Corp. announced on August 13, 2024, that it has entered into a definitive agreement to acquire Peraton Labs, a subsidiary of Peraton Inc. This acquisition is expected to enhance Booz Allen's capabilities in advanced research and development, particularly in areas like artificial intelligence and cyber. The transaction is anticipated to close in the third quarter of fiscal year 2025.

Why It Matters

This acquisition signals Booz Allen Hamilton's strategic move to bolster its R&D and AI capabilities, potentially positioning it for greater success in government contracting.

Risk Assessment

Risk Level: medium — Acquisitions carry inherent integration risks and may not achieve expected synergies, impacting financial performance.

Key Players & Entities

FAQ

What is the primary strategic rationale behind Booz Allen Hamilton's acquisition of Peraton Labs?

The acquisition is intended to enhance Booz Allen Hamilton's capabilities in advanced research and development, particularly in areas such as artificial intelligence and cyber.

When is the acquisition of Peraton Labs expected to be completed?

The transaction is anticipated to close in the third quarter of fiscal year 2025.

Which subsidiary is Booz Allen Hamilton acquiring?

Booz Allen Hamilton is acquiring Peraton Labs, a subsidiary of Peraton Inc.

What specific technological areas will be strengthened by this acquisition?

The acquisition is expected to strengthen capabilities in advanced research and development, specifically mentioning artificial intelligence and cyber.

What is the filing date of this 8-K report?

This 8-K report was filed on August 13, 2024.

Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-08-13 17:22:26

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Booz Allen Hamilton Holding Corporation (the "Company") expects to present the attached materials to certain investors on or after August 13, 2024. The materials may be used by the Company in various other presentations to investors. A copy of the materials is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01 and Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Investor Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Booz Allen Hamilton Holding Corporation BY: /s/ Matthew A. Calderone Matthew A. Calderone Executive Vice President and Chief Financial Officer Date: August 13, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing